Gregory Driessens

Affiliations

iTeos Therapeutics, Gosselies, Belgium.

Réseau de co-auteurs

Julie Preillon 2 collaborations

Simone A Minnie 1 collaboration

Olivia G Waltner 1 collaboration

Kathleen S Ensbey 1 collaboration

Stuart D Olver 1 collaboration

Alika D Collinge 1 collaboration

David P Sester 1 collaboration

Christine R Schmidt 1 collaboration

Samuel Rw Legg 1 collaboration

Shuichiro Takahashi 1 collaboration

Nicole S Nemychenkov 1 collaboration

Tomoko Sekiguchi 1 collaboration

Ping Zhang 1 collaboration

Motoko Koyama 1 collaboration

Andrew Spencer 1 collaboration

Leona A Holmberg 1 collaboration

Scott N Furlan 1 collaboration

Antiopi Varelias 1 collaboration

Geoffrey R Hill 1 collaboration

Florence Schramme 1 collaboration

Stefano Crosignani 1 collaboration

Kim Frederix 1 collaboration

Delia Hoffmann 1 collaboration

Luc Pilotte 1 collaboration

Vincent Stroobant 1 collaboration

Benoit J Van den Eynde 1 collaboration

Julia Cuende 1 collaboration

Virginie Rabolli 1 collaboration

Lucile Garnero 1 collaboration

Marjorie Mercier 1 collaboration

Noémie Wald 1 collaboration

Angela Pappalardo 1 collaboration

Sofie Denies 1 collaboration

Diane Jamart 1 collaboration

Anne-Catherine Michaux 1 collaboration

Romain Pirson 1 collaboration

Vincent Pitard 1 collaboration

Martine Bagot 1 collaboration

Shruthi Prasad 1 collaboration

Erica Houthuys 1 collaboration

Margreet Brouwer 1 collaboration

Reece Marillier 1 collaboration

Florence Lambolez 1 collaboration

Joäo R Marchante 1 collaboration

Florence Nyawouame 1 collaboration

Mathew J Carter 1 collaboration

Véronique Baron-Bodo 1 collaboration

Anne Marie-Cardine 1 collaboration

Mark Cragg 1 collaboration

Julie Déchanet-Merville 1 collaboration

Catherine Hoofd 1 collaboration

Gregory Driessens

Affiliations

Publications (3)

TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in mice.

Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors.

Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies.

Réseau de co-auteurs